• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单克隆抗体识别的L - 1210白血病细胞表面抗原

Cell surface antigens of L-1210 leukemia recognized by monoclonal antibodies.

作者信息

Szkudlarek J, Steuden I, Salwa J, Radzikowski C

出版信息

Arch Immunol Ther Exp (Warsz). 1984;32(6):671-5.

PMID:6536238
Abstract

Conventional antisera to L-1210 leukemia were being prepared in our laboratory for nearly a decade and consistently the only specificity detectable was anti Mammary Leukemia antigen (ML). Serological analysis of five monoclonal antibodies obtained following the same immunization schedule showed more diverse pattern of reactivity. Two antigens detected belong to oncofetal category. The third one is differentiation antigen Ly-6 and the nature of two others, expressed on leukemic cells only, remains at present unclear. Thus none of the clones analysed produces antibodies to ML antigen. Our previous analysis of cell surface antigens of L-1210 leukemia with the use of conventional antisera has already been described. This paper presents the results of applying monoclonal antibodies in a comparable studies.

摘要

近十年来,我们实验室一直在制备针对L - 1210白血病的传统抗血清,始终检测到的唯一特异性是抗乳腺白血病抗原(ML)。按照相同免疫方案获得的五种单克隆抗体的血清学分析显示出更多样化的反应模式。检测到的两种抗原属于癌胚抗原类别。第三种是分化抗原Ly - 6,另外两种仅在白血病细胞上表达的抗原的性质目前尚不清楚。因此,分析的克隆中没有一个产生针对ML抗原的抗体。我们之前使用传统抗血清对L - 1210白血病细胞表面抗原的分析已经描述过。本文介绍了在类似研究中应用单克隆抗体的结果。

相似文献

1
Cell surface antigens of L-1210 leukemia recognized by monoclonal antibodies.单克隆抗体识别的L - 1210白血病细胞表面抗原
Arch Immunol Ther Exp (Warsz). 1984;32(6):671-5.
2
Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.DBA/2淋巴瘤L1210及其亚系的差异抗原表达:同基因单克隆抗体所定义的与C3H乳腺肿瘤的交叉反应性。
Cancer Res. 1983 Jun;43(6):2592-9.
3
Identification and characterization of a unique tumor-associated surface antigen on L1210 leukemia cells recognized by semisyngeneic antisera.L1210白血病细胞上一种独特的肿瘤相关表面抗原的鉴定与特性分析,该抗原可被半同基因抗血清识别。
Cancer Res. 1987 Feb 15;47(4):1006-9.
4
Studies on cell surface antigens of mouse leukemic and normal lymphocytes. II. Relationships between mammary leukemia, gross virus related and major histocompatibility antigens on L1210 leukemic lymphocytes.小鼠白血病及正常淋巴细胞细胞表面抗原的研究。II. L1210白血病淋巴细胞上乳腺白血病、与病毒相关的总抗原及主要组织相容性抗原之间的关系。
Arch Immunol Ther Exp (Warsz). 1978;26(1-6):95-7.
5
Studies on the distribution of the antigens detected by some newly prepared monoclonal antibodies in normal hemopoietic and leukemic cells.
Neoplasma. 1985;32(6):657-62.
6
Monoclonal antibodies to the L1210 murine leukemia cell line and to a drug-altered subline.针对L1210小鼠白血病细胞系及一种药物诱导的亚系的单克隆抗体。
Cancer Res. 1985 Nov;45(11 Pt 1):5299-303.
7
Studies on cell surface antigens of mouse leukemic and normal lymphocytes. I. Categories of cell surface antigens on mouse leukemia and their serological identification.小鼠白血病和正常淋巴细胞细胞表面抗原的研究。I. 小鼠白血病细胞表面抗原的类别及其血清学鉴定。
Arch Immunol Ther Exp (Warsz). 1978;26(1-6):89-93.
8
Serological identification of viral and virus-related antigens on DBA/2 mouse leukemia lymphocytes.
Arch Immunol Ther Exp (Warsz). 1979;27(1-2):187-207.
9
Surface antigens defined by monoclonal antibodies as tumor markers in human leukemia.由单克隆抗体定义的表面抗原作为人类白血病中的肿瘤标志物。
Cancer Detect Prev. 1983;6(1-2):281-6.
10
Differential expression of murine leukemia antigen on L1210 parental and drug-resistant sublines.小鼠白血病抗原在L1210亲本细胞系及耐药亚系中的差异表达
Cancer Res. 1981 Dec;41(12 Pt 1):4934-7.

引用本文的文献

1
Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide.用马磷酰胺清除白血病后进行骨髓放疗及移植,对微小残留病成功进行过继性免疫治疗。
Cancer Immunol Immunother. 1990;32(1):71-4. doi: 10.1007/BF01741728.